Chimerix Inc (CMRX)

$0.88 0.05 (5.14%)

16:00 EDT CMRX Stock Quote Delayed 30 Minutes

CMRX Stock Warning! Smart Biotech Investors Will Avoid Chimerix Like the Plague.

By Louis Navellier and the InvestorPlace Research Staff Aug 11, 2023

While the story could change down the road, for now your best move is to avoid CMRX stock, even as a small, speculative position.

7 Millionaire-Maker Penny Stocks to Buy Before the Window Closes

7 Small-Cap Stocks to Buy Before the Breakout

Why These 7 Stocks Are the Best Ways to Play Biotech Right Now

Volume:

Previous Close -

Market Cap 76.28M

PE Ratio -0.95

EPS -0.93

Volume (Avg. Vol.) 427,003

Day's Range $0.88 - $0.94

52-Week Range $0.88 - $1.57

Dividend & Yield N/A (N/A)

CMRX Stock Predictions, Articles, and Chimerix Inc News

From InvestorPlace
From the Web

7 Deeply Undervalued Growth Stocks to Buy in June

By Josh Enomoto, InvestorPlace Contributor Jun 1, 2023

If you want to enliven your portfolio with high potential bargains, these best undervalued growth stocks for June might fit the bill.

7 Thrilling Biotech Stocks for Aggressive Investors to Buy

By Josh Enomoto, InvestorPlace Contributor Apr 5, 2023

Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own.

The Top 7 Growth Stocks in Biotech

By Alex Sirois, InvestorPlace Contributor Mar 3, 2023

The biotech sector always houses a great selection of growth stocks that can grow rapidly and reward investors over the long-term.

7 Overlooked Value Stocks That Could Outperform the Market

By Josh Enomoto, InvestorPlace Contributor Feb 13, 2023

For those investors seeking bargain opportunities with massive upside potential, these overlooked value stocks should fit the bill.

The 7 Best Biotech Stocks to Buy for February 2023

By Josh Enomoto, InvestorPlace Contributor Feb 7, 2023

Following the wave of red ink last year, astute investors should target the best biotech stocks to buy this month for strong growth potential.

The 7 Most Undervalued Biotech Stocks to Buy in February 2023

By Josh Enomoto, InvestorPlace Contributor Feb 2, 2023

Get your hands on the latest medical innovations at a compelling discount with the most undervalued biotech stocks to buy.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Nov 3, 2022

We're starting off the day with a look at the latest news behind the biggest pre-market stock movers for Thursday morning!

7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher

By Tezcan Gecgil, InvestorPlace Contributor Aug 17, 2022

These monkeypox stocks could be among the best choices to buy in August. Each can make great investments as government responses ramp up.

Monkeypox Stocks SIGA, GOVX, BVNRY, CHMX, EBS Soar on Global Health Emergency

By Dana Blankenhorn, InvestorPlace Contributor Jul 25, 2022

Drugs and vaccines used against smallpox are seen as the first line of defense against the rising tide of monkeypox infections.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Jul 25, 2022

Good morning, investor! We're starting off this week of trading with a look at the biggest pre-market stock movers for Monday!

Monkeypox Stocks BVNRY, EBS, CMRX, SIGA Heat Up on U.S. Vaccine Stockpile

By Joel Baglole, InvestorPlace Contributor Jun 29, 2022

Stocks related to the treatment of monkeypox are heating up today on news that the U.S. is building a vaccine stockpile and will offer vaccine appointments to individuals who are at risk of contracting the virus.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Jun 27, 2022

Good morning, trader! We're starting off the week with an overview of the biggest pre-market stock movers for Monday morning!

7 Penny Stocks That Could Triple in 2022

By Shanthi Rexaline Jun 22, 2022

Some stocks currently trading in penny stock territory have unique advantages that makes it worthwhile to overlook the inherent risk involved in investing in these stocks.

7 Monkeypox Stocks That May Take Off in Q2

By Brian Paradza, CFA Jun 9, 2022

SIGA Technologies (SIGA) may lead on the list of monkeypox stocks that could soar, but Bavarian Nordic seems to be leading the sales race.

7 Monkeypox Stocks to Watch Right Now

By Samuel O'Brient, InvestorPlace Reporter May 24, 2022

Wondering what are the best monkeypox stocks to watch? Here are the companies producing vaccines to help fight the spread of the virus.

Chimerix (CMRX) Stock Plummets 60% After Q1 Earnings Disappointment

By William White, InvestorPlace Writer May 16, 2022

Chimerix (CMRX) stock is falling hard on Monday following the release of its earnings report for the first quarter of 2022.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer May 16, 2022

Welcome back and get ready for another busy week of trading as we start it off with the biggest pre-market stock movers for Monday!

27 Biotechnology Stocks to Sell Now

By Portfolio Grader May 16, 2016

The ratings of 27 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

11 Biotechnology Stocks to Buy Now

By Portfolio Grader Nov 26, 2014

This week, 11 biotechnology stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").

These Ebola Stocks Have It All Riding on Africa Drug Trials

By Jeff Reeves Nov 13, 2014

Ebola stocks have been volatile in 2014 as investors bet on drugmakers. In 2015, Africa drug trials mean everything to ebola stocks.

Chimerix files for $250M mixed shelf offering (NASDAQ:CMRX)

From Seeking Alpha Feb 29, 2024

Chimerix files prospectus for $250M mixed shelf offering, however, it does not indicate an offer to sell.

Lightning Could Strike Twice for Biotech Penny Stock Chimerix (NASDAQ:CMRX)

From TipRanks Jan 9, 2024

Ordinarily, investors – especially conservative buy-and-hold types – are much better off ignoring penny stocks. They’re too wild, too unpredictable, and far too man...

Chimerix promotes Michelle Laspaluto to CFO (NASDAQ:CMRX)

From Seeking Alpha Dec 4, 2023

Chimerix (CMRX) has promoted Michelle LaSpaluto, Vice President of Corporate Financial Planning and Investor Relations, to Chief Financial Officer effective Dec

Chimerix names Thomas Riga as Chief Operating and Commercial Officer (NASDAQ:CMRX)

From Seeking Alpha Nov 16, 2023

Chimerix appoints Thomas Riga as Chief Operating and Commercial Officer, enhancing their executive leadership team.

Chimerix promotes CFO to CEO post (NASDAQ:CMRX)

From Seeking Alpha Jun 27, 2023

Biopharmaceutical company Chimerix (CMRX) said on Tuesday that Chief Business Officer and CFO Mike Andriole has been promoted to the post of president and CEO.

Analysts Are Bullish on These Healthcare Stocks: Urogen Pharma (URGN), Kura Oncology (KURA)

From TipRanks Dec 12, 2022

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Urogen Pharma (URGN – Research Report), Kura Oncolog...

Chimerix Inc (CMRX)

CMRX Stock Warning! Smart Biotech Investors Will Avoid Chimerix Like the Plague.

7 Millionaire-Maker Penny Stocks to Buy Before the Window Closes

7 Small-Cap Stocks to Buy Before the Breakout

Why These 7 Stocks Are the Best Ways to Play Biotech Right Now

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Chimerix Inc (CMRX)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

CMRX Stock Predictions, Articles, and Chimerix Inc News

Subscriber Sign in